Home/Cue Biopharma/Lucinda Warren
LW

Lucinda Warren

Chief Financial Officer and Business Officer (CFBO)

Cue Biopharma

Cue Biopharma Pipeline

DrugIndicationPhase
CUE-101 / CUE-100 Series (representative)HPV+ Head and Neck Cancer / Solid TumorsPhase 1/2
Immuno-STAT Autoimmune ProgramAutoimmune Disease (undisclosed)Preclinical
Cell Therapy ApproachSolid TumorsDiscovery